Marjan Rouzbahman

Mount Sinai Hospital
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Contemporary issues in the multi-disciplinary management of early-stage uterine sarcoma.

Contemporary issues in the multi-disciplinary management of early-stage uterine sarcoma.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 26, 2026

Multi-disciplinary management of advanced uterine sarcoma: a state of the art review.

Multi-disciplinary management of advanced uterine sarcoma: a state of the art review.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 26, 2026

Oncologic and fertility outcomes of progestin therapy for atypical hyperplasia and grade 1 cancer of the endometrium: Results of a specialized oncofertility program.

Oncologic and fertility outcomes of progestin therapy for atypical hyperplasia and grade 1 cancer of the endometrium: Results of a specialized oncofertility program.

Journal: Gynecologic oncology

Published: April 19, 2025

Canadian Management of Serous Tubal Intraepithelial Carcinoma.

Canadian Management of Serous Tubal Intraepithelial Carcinoma.

Journal: Obstetrics and gynecology

Published: February 27, 2025

Assessment of Interobserver Agreement Among Gynecologic Pathologists Between Three-Tier Versus Binary Pattern-based Classification Systems for HPV-associated Endocervical Adenocarcinoma.

Assessment of Interobserver Agreement Among Gynecologic Pathologists Between Three-Tier Versus Binary Pattern-based Classification Systems for HPV-associated Endocervical Adenocarcinoma.

Journal: The American journal of surgical pathology

Published: July 17, 2024

Multiparametric MRI radiomics for predicting disease-free survival and high-risk histopathological features for tumor recurrence in endometrial cancer.

Multiparametric MRI radiomics for predicting disease-free survival and high-risk histopathological features for tumor recurrence in endometrial cancer.

Journal: Frontiers in oncology

Published: March 25, 2024

HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring.

HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: March 04, 2024

Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinoma.

Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinoma.

Journal: Gynecologic oncology

Published: January 04, 2024

Targeted RNA Sequencing Highlights a Diverse Genomic and Morphologic Landscape in Low-grade Endometrial Stromal Sarcoma, Including Novel Fusion Genes.

Targeted RNA Sequencing Highlights a Diverse Genomic and Morphologic Landscape in Low-grade Endometrial Stromal Sarcoma, Including Novel Fusion Genes.

Journal: The American journal of surgical pathology

Published: October 23, 2023

Heterogeneity and treatment landscape of ovarian carcinoma.

Heterogeneity and treatment landscape of ovarian carcinoma.

Journal: Nature reviews. Clinical oncology

Published: September 04, 2023

Diagnostic accuracy of frozen section and patterns of nodal spread in high grade endometrial cancer: A secondary outcome of the SENTOR prospective cohort study.

Diagnostic accuracy of frozen section and patterns of nodal spread in high grade endometrial cancer: A secondary outcome of the SENTOR prospective cohort study.

Journal: Gynecologic oncology

Published: July 29, 2022

A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer.

A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 30, 2022

Showing 1-12 of 45

Last Updated: 09/26/2026